3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
19
Neoplasms
3
Prostatic Neoplasms, Castration-Resistant
2
Neoplasm Metastasis
2
Metastatic Hormone-sensitive Prostate Cancer
2
Metastatic Castration-Resistant Prostate Cancer
2
Small Cell Lung Carcinoma
1
Recurrence
1
Prostate Adenocarcinoma
1
PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy
1
Metastatic Castration-resistant Prostate Neoplasms
1
Metastatic Castration-resistant Prostate Cancer
1
Lymphoma, Follicular
1
Colorectal Neoplasms
1
Castrate Sensitive Prostate Cancer
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Bulbo-Spinal Atrophy, X-Linked
1
Bites and Stings
1
Advanced Prostate Cancer
1
Adenocarcinoma
1
Interventions
Nivolumab
3
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
Biopsy
2
trastuzumab deruxtecan
1
X-Rays
1
Watchful Waiting
1
Tomography, X-Ray Computed
1
Taxes
1
Sigmoidoscopy
1
Radionuclide Imaging
1
Proctoscopy
1
Phantoms, Imaging
1
Paclitaxel
1
Observation
1
Mn(III) meso-tetrakis(N-n-butoxyethylpyridinium-2-yl)porphyrin
1
Magnetic Resonance Imaging
1
Ipilimumab
1
Ibuprofen
1
Epinephrine
1
Electrocardiography
1
Diphenhydramine
1
Dexamethasone
1
Colonoscopy
1
Carboplatin
1
Calcium Dobesilate
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anus Neoplasms
×
enzalutamide
×
30 days
×
Clear all
No trials found.